文献速递慢病防控与筛查免疫规划

带状疱疹疫苗降低慢性病患者卒中与心肌梗死风险

Zoster Vaccine Lowers Stroke and Myocardial Infarction Risk in Chronic Disease.
PubMed 文献 · Am J Prev Med · 2024-06-22

该回顾性队列研究利用2005—2018年IBM MarketScan商业索赔数据库,纳入27,093名接种减毒活带状疱疹疫苗的成人并按年龄性别1:5匹配未接种对照,发现接种者5年内卒中与心肌梗死比例低于未接种者,合并症亚组中接种仍与风险降低相关。

要点

  • 接种组5年内心肌梗死比例1.29% vs 未接种组1.82%(p<0.05)。
  • 接种组5年内卒中比例1.61% vs 未接种组2.20%(p<0.05)。
  • 糖尿病患者接种者卒中OR=0.64(95%CI 0.58,0.71)、心肌梗死OR=0.63(95%CI 0.57,0.71)。

核心结论

  • 在合并高血压、糖尿病、肥胖、高胆固醇血症、慢性肾脏病、慢性阻塞性肺疾病、肺气肿、哮喘和慢性肝病等带状疱疹风险人群中,接种减毒活带状疱疹疫苗与较低的卒中和心肌梗死风险相关(控制年龄和性别)。
  • 接种可能提供带状疱疹预防之外的心血管获益。

研究设计与样本

  • 回顾性队列研究,使用IBM MarketScan商业索赔与 encounters 数据库2005—2018年连续去标识化索赔数据,覆盖2亿商业保险美国人。
  • 纳入27,093名接种带状疱疹疫苗且至少连续参保5年的成人,按年龄和性别1:5匹配未接种对照。
  • 采用OR、风险差和需治疗人数评估接种对卒中和心肌梗死的影响,并控制相关合并症。

主要发现

  • 5年期间,接种组心肌梗死比例1.29% vs 未接种组1.82%(p<0.05),接种组卒中比例1.61% vs 未接种组2.20%(p<0.05),控制年龄和性别。
  • 糖尿病患者获益最大:卒中OR=0.64(95%CI 0.58,0.71),心肌梗死OR=0.63(95%CI 0.57,0.71)。
  • 高血压和慢性阻塞性肺疾病患者卒中和心肌梗死几率最高,但接种仍提供显著风险降低:高血压卒中OR=0.75(95%CI 0.68,0.83)、心肌梗死OR=0.73(95%CI 0.65,0.81);慢性阻塞性肺疾病卒中OR=0.75(95%CI 0.68,0.83)、心肌梗死OR=0.74(95%CI 0.66,0.83)。

临床怎么用

  • 原文结论指出,接种减毒活带状疱疹疫苗与合并症成人较低的卒中和心肌梗死风险相关,可能提供带状疱疹预防之外的心血管获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Herpes zoster increases stroke and myocardial infarction risk. The objective of this study is to evaluate the impact of live attenuated zoster vaccination on stroke and myocardial infarction risk in patients at risk of zoster, including those with hypertension, diabetes mellites, obesity, hypercholesterolemia, chronic kidney disease, chronic obstructive pulmonary disease, emphysema, asthma, and chronic liver disease. METHODS: This is a retrospective cohort study utilizing continuous de-identified claims data from the IBM MarketScan Commercial Claims and Encounters Database (collected from 2005-2018) containing data for 200 million commercially insured Americans. Participants included 27,093 adults vaccinated against zoster with at least 5 years of continuous enrollment, age and sex-matched 1:5 with unvaccinated controls. OR, risk difference, and the number needed to treat evaluated the effect of vaccination on stroke and myocardial infarction while controlling for relevant comorbidities. RESULTS: Over the period of 5 years, proportions of myocardial infarction (1.29% vs 1.82%; p<0.05) and stroke (1.61% vs 2.20%; p<0.05) were lower in vaccinated versus unvaccinated individuals, respectively, controlling for age and sex, with the greatest benefit for people with diabetes (stroke OR=0.64, 95% CI=0.58, 0.71; myocardial infarction OR=0.63, 95% CI=0.57, 0.71). Although hypertension and chronic obstructive pulmonary disease had the highest odds of stroke and myocardial infarction, vaccination still provided significant risk-reduction (hypertension: stroke 0.75 [0.68, 0.83], myocardial infarction 0.73 [0.65, 0.81]; chronic obstructive pulmonary disease: stroke 0.75 [0.68, 0.83], myocardial infarction 0.74 [0.66, 0.83]). CONCLUSIONS: Live attenuated zoster vaccination is associated with lower risk of stroke and myocardial infarction in adults with at-risk comorbidities, controlling for age and sex. Vaccination may provide cardiovascular benefits beyond zoster prevention.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Helm MF, Khoury PA, Warne M, et al. Zoster Vaccine Lowers Stroke and Myocardial Infarction Risk in Chronic Disease. Am J Prev Med. 2024. PMID: 38909663. doi:10.1016/j.amepre.2024.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。